Widespread distribution of nirsevimab to infants with respiratory syncytial virus infection raised concerns about potential ...

The drug was 88% effective against the need for medical attention among those in their second respiratory virus season.

Some Alberta doctors are calling on the provincial government to make an injection designed to protect newborns from severe ...

A WHO official this week said repatriation is one of multiple factors fueling rises in Pakistan and Afghanistan.

Current guidelines recommend that pregnant people receive a vaccine against respiratory syncytial virus (RSV) -- which typically causes mild, cold-like symptoms in most adults but can be deadly for ...

The following is a summary of “Safety and Pharmacokinetics of Nirsevimab in Immunocompromised Children,” published in the September 2024 issue of Pediatrics by Domachowske et al. Children who are ...

The following is a summary of “Nirsevimab and Acute Bronchiolitis Episodes in Pediatric Emergency Departments,” published in the September 2024 issue of Pediatrics by Martínez et al. In the 2023–2024 ...

The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...

Infants will be able to receive a free immunisation to protect them against serious illness from respiratory syncytial virus (RSV), under a new $16.6 million NSW Government RSV prevention program to ...

A Winnipeg mother with a newborn is pleading with the province to start offering RSV shots to all babies. As we navigate ...

Nirsevimab has been hailed by Sanofi chief executive Paul Hudson as one of the brightest prospects in the company's pipeline, providing a brand new way to tackle RSV, which according to the World ...